← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Valle
Cali
$616,576
Total funding
10
Grants
Funding over time
peak $807.6K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$616,576 · 10
By mechanism
D43$425,256 · 1
R01$191,320 · 1
P50$0 · 8
Investigators at University Of Valle
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Translation Research in Plasmodium vivax$741,583
P50 · FY2002 · AI
Translation Research in Plasmodium vivax$738,366
P50 · FY2003 · AI
Translation Research in Plasmodium vivax$733,249
P50 · FY2004 · AI
Translation Research in Plasmodium vivax$701,251
P50 · FY2005 · AI
Translation Research in Plasmodium vivax$578,610
P50 · FY2001 · AI
Hydrolytically stable hydrophilic CE coatings for protein characterization$123,600
R01 · FY2010 · GM
Physipatogenesis of malaria anemia in humans &monkeys$106,314
D43 · FY2002 · TW
Physipatogenesis of malaria anemia in humans &monkeys$106,314
D43 · FY2004 · TW
Physipatogenesis of malaria anemia in humans &monkeys$106,314
D43 · FY2003 · TW
Physipatogenesis of malaria anemia in humans &monkeys$106,314
D43 · FY2005 · TW
Hydrolytically stable hydrophilic CE coatings for protein characterization$38,556
R01 · FY2011 · GM
Hydrolytically stable hydrophilic CE coatings for protein characterization$29,164
R01 · FY2012 · GM
Aotus Model for Assessment of P vivax Candidate Vaccines$0
P50 · FY2001 · AI
Core--Field Site /INSALPA$0
P50 · FY2001 · AI
Core--Field Site /INSALPA$0
P50 · FY2002 · AI
Natural Plasmodium vivax Transmission Blocking Responses$0
P50 · FY2002 · AI
Plasmodium vivax Irradiated Sporozoite Vaccine$0
P50 · FY2002 · AI
Aotus Model for Assessment of P vivax Candidate Vaccines$0
P50 · FY2002 · AI
Core--Immunology Institute$0
P50 · FY2002 · AI
Core--Clinical Facility$0
P50 · FY2002 · AI